Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SCNX Scienture Holdings, Inc.

盘前交易 09-01 06:05:45 EDT

0.3885

-0.0055

-1.40%

盘前0.3885

+0.00000.00%

04:52 EDT

最高0.3940	最低0.3767	成交量15.36万
今开0.3940	昨收0.3940	日振幅4.39%
总市值1,595万	流通市值1,318万	总股本4,106万
成交额5.94万	换手率0.45%	流通股本3,392万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.3885,"timestamp":1788206400000,"preClose":0.394,"halted":0,"volume":153623,"hourTrading":{"tag":"盘前","latestPrice":0.3885,"preClose":0.3885,"latestTime":"04:52 EDT","volume":1428,"amount":554.778,"timestamp":1788252749219,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.013959390862944175,"floatShares":33915538,"shares":41064146,"eps":-2.03,"marketStatus":"盘前交易","change":-0.0055,"latestTime":"09-01 06:05:45 EDT","open":0.394,"high":0.394,"low":0.3767,"amount":59365.694207420005,"amplitude":0.043909,"askPrice":0.4804,"askSize":100,"bidPrice":0.3553,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.03,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.3885,"preHourTrading":{"tag":"盘前","latestPrice":0.3885,"preClose":0.3885,"latestTime":"04:52 EDT","volume":1428,"amount":554.778,"timestamp":1788252749219,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.382,"preClose":0.3885,"latestTime":"19:54 EDT","volume":10637,"amount":4053.0796,"timestamp":1788220488789,"change":-0.0065,"changeRate":-0.016731,"amplitude":0.019305},"volumeRatio":0.48011568539125216},"requestUrl":"/m/hq/s/SCNX","defaultTab":"news","newsList":[{"id":"1112132128","title":"Scienture Holdings Q2 2026业绩出炉：营收环比暴增约510%，运营表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1112132128","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112132128?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:09","pubTimestamp":1786709350,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日公布了2026年第二季度财务报告。与第一季度相比，公司营收实现了令人瞩目的飞跃——环比增幅高达约510%。与此同时，运营绩效也呈现出显著的优化态势。具体而言，Scienture在第二季度不仅成功扭转了此前季度相对疲软的增长态势，更在成本控制与业务结构优化上取得了实质性突破。尽管当前宏观环境仍存变数，但Scienture凭借这一季度的超预期表现，已向投资者展示了其强劲的成长韧性与执行能力。此次财报，或将成为公司估值重塑的关键催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198130031","title":"Scienture宣布Rezenopy™正式上市，首批订单已交付——这是FDA批准的最高剂量纳洛酮鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1198130031","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198130031?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:06","pubTimestamp":1786536370,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日发布公告，正式启动Rezenopy™的商业化上市，并已完成首批采购订单的履约交付。Rezenopy™作为美国食品药品监督管理局（FDA）批准的最高剂量纳洛酮鼻喷雾剂，标志着公司在阿片类药物过量逆转领域迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197083931","title":"Scienture公布2026年第一季度财报：营收强劲增长，毛利率显著扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1197083931","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197083931?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:39","pubTimestamp":1779107951,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.发布了2026年第一季度财务业绩及业务进展。报告期内，公司实现了显著的营收增长，同时毛利率亦获得有力扩张，展现出强劲的业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143008554","title":"Scienture Holdings与Summit Biosciences达成最终协议 获得Rezenopy美国独家商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1143008554","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143008554?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:14","pubTimestamp":1778156056,"startTime":"0","endTime":"0","summary":"Scienture Holdings已与Summit Biosciences签署最终协议，获得抗抑郁药物Rezenopy在美国市场的独家商业化权利。此次合作将进一步加强Scienture Holdings在神经科学领域的市场布局。\n根据协议条款，Scienture Holdings将负责Rezenopy在美国境内的所有商业化活动，包括市场推广、销售和分销。该交易标志着公司向精神健康治疗领域迈出重要一步。\nRezenopy作为一种新型抗抑郁药物，在临床试验中展现出良好的疗效和安全性。此次独家授权协议的达成，将为Scienture Holdings带来新的收入增长点，并扩大其产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178090977","title":"Scienture获得1100万美元非稀释性债务融资 加速已获批产品组合扩张及研发管线推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1178090977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178090977?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:06","pubTimestamp":1778155590,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (简称Scienture) 近日成功获得1100万美元非稀释性债务融资。此次融资将主要用于加速公司已获批产品组合的商业化增长，并推动研发管线的持续进展。非稀释性融资模式使得Scienture能够在不动用股权的情况下获得资金支持，有效保护了现有股东利益。这笔资金将助力公司扩大市场份额，加强产品创新，为长期发展注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164857739","title":"Scienture Holdings获纳斯达克180天宽限期 需在此期间恢复最低股价合规要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1164857739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164857739?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:05","pubTimestamp":1776254717,"startTime":"0","endTime":"0","summary":"纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期，该公司须在此期间内将其股价提升至1美元以上，以满足交易所的最低报价规定。\n此次延期为这家生物科技企业提供了关键缓冲期，使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规，公司将面临退市风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176660109","title":"Scienture Holdings, Inc.通过集团采购协议扩大Rezenopy™的商业可及性，覆盖全美超5,000家机构","url":"https://stock-news.laohu8.com/highlight/detail?id=1176660109","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176660109?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:13","pubTimestamp":1773231202,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (SCNX) 已成功拓展其旗舰产品Rezenopy™的商业覆盖范围。该产品是当前获得美国食品药品监督管理局（FDA）批准的最高剂量纳洛酮鼻喷雾剂。通过达成一系列集团采购组织（GPO）协议，公司显著提升了这款关键药物的市场可及性。\n此次合作将直接惠及美国境内超过5,000家医疗机构，包括医院、诊所和社区健康中心等。此举旨在确保更多有需要的人群能够及时获得这种高效的阿片类药物过量逆转疗法。Rezenopy™的高剂量特性为其在紧急情况下快速起效提供了保障，对应对阿片危机具有重要价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":-0.1019},{"period":"1month","weight":0.0205},{"period":"3month","weight":-0.0061},{"period":"6month","weight":-0.0288},{"period":"1year","weight":-0.6015},{"period":"ytd","weight":-0.2382}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1196},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.1248}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scienture Holdings, Inc.于2005年7月15日在特拉华州注册成立。该公司的主要运营子公司是Scienture，LLC。Scienture LLC是一家专业制药公司，专注于心血管（“CVS”）和中枢神经系统（“CNS”）疾病治疗产品的商业化和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.09045},{"month":6,"riseRate":0.857143,"avgChangeRate":0.461559},{"month":7,"riseRate":0.714286,"avgChangeRate":0.094869},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.141065},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.047954},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}